- Home
- INVH vs FMS Comparison
INVH vs FMS Comparison
Compare INVH & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INVH | FMS |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Real Estate | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 13.9B |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | INVH | FMS |
|---|---|---|
| Price | $27.62 | $21.97 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 16 | 2 |
| Target Price | ★ $34.53 | $30.00 |
| AVG Volume (30 Days) | ★ 7.0M | 426.9K |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.43% | 2.63% |
| EPS Growth | ★ 32.35 | 8.62 |
| EPS | 0.95 | ★ 2.86 |
| Revenue | $2,689,621,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $5.81 | $2.13 |
| Revenue Next Year | $3.17 | $2.95 |
| P/E Ratio | $28.48 | ★ $14.22 |
| Revenue Growth | ★ 5.29 | 2.10 |
| 52 Week Low | $25.29 | $21.02 |
| 52 Week High | $35.80 | $30.46 |
Technical Indicators
Market Signals| Indicator | INVH | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 37.86 |
| Support Level | $25.98 | $21.02 |
| Resistance Level | $26.95 | $23.93 |
| Average True Range (ATR) | 0.71 | 0.40 |
| MACD | 0.02 | -0.19 |
| Stochastic Oscillator | 74.14 | 31.91 |
Price Performance
Historical ComparisonAbout INVH Invitation Homes Inc.
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.